13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Sidley Represents ADARx Pharmaceuticals in Its US$200 Million Series C Financing
Sidley represented ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing next-generation RNA therapeutics, in its successful close of an…
Clifford Chance advises WEKA Group on the sale of its education business to Aspire Education Group
Clifford Chance has advised Paragon Partners and its WEKA Group portfolio companies, which offer specialist media and communications services, on…
Kirkland Advises Consortium Led by Sandbrook Capital on Agreement to Acquire NeXtWind
Kirkland & Ellis advised a consortium led by Sandbrook Capital on signing an agreement to acquire NeXtWind Capital Ltd (“NeXtWind”),…
Dentons advises BGK and KUKE on financing of HiProMine’s innovative investment projects
Dentons has advised Poland’s state development bank, Bank Gospodarstwa Krajowego (BGK), and state export credit agency, Korporacja UbezpieczeĹ„ KredytĂłw Eksportowych…
Latham & Watkins Advises WaterBridge NDB in the Strategic Partnership With Devon Energy
WaterBridge NDB LLC (together with its subsidiaries, WaterBridge NDB), a portfolio company of Five Point Energy LLC (Five Point), announced…
Latham & Watkins Advises on Mirati Therapeutics’ Pricing of Upsized Public Offering
Mirati Therapeutics, Inc. (Nasdaq: MRTX), a commercial stage biotechnology company, has announced the pricing of an underwritten public offering of…
